Ignite Creation Date:
2024-05-05 @ 11:43 AM
Last Modification Date:
2024-10-26 @ 9:12 AM
Study NCT ID:
NCT00114959
Status:
TERMINATED
Last Update Posted:
2015-01-15
First Post:
2005-06-20
Brief Title:
Homoharringtonine With Oral Gleevec in Chronic Accelerated and Blast Phase Chronic Myeloid Leukemia CML
Sponsor:
ChemGenex Pharmaceuticals
Organization:
Teva Branded Pharmaceutical Products RD Inc
Organization Data
Organization:
Teva Branded Pharmaceutical Products RD Inc
Class:
INDUSTRY
Study ID:
CGX-635-CML-201
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
ChemGenex Pharmaceuticals
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None